Pimecrolimus cream, 1%, vs hydrocortisone acetate cream, 1%, in the treatment of facial seborrheic dermatitis: A randomized, investigator-blind, clinical trial

Archives of Dermatology

Volumn 142, Issue 8, 2006, Pages 1066-1067

  Firooz, Alireza ^a   Solhpour, Amirreza ^b   Gorouhi, Farzam ^b   Daneshpazhooh, Maryam ^b   Balighi, Kamran ^b   Farsinejad, Khalil ^b   Rashighi Firoozabadi, Mehdi ^b   Dowlati, Yahya ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE VALERATE; CORTICOSTEROID; DERMAID; HYDROCORTISONE ACETATE; PIMECROLIMUS;

ADULT; ARTICLE; BURNING SENSATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG TOLERANCE; ERYTHEMA; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; PHOTOTHERAPY; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SEBORRHEIC DERMATITIS;

ADMINISTRATION, CUTANEOUS; ADULT; CALCINEURIN; DERMATITIS, SEBORRHEIC; DERMATOLOGIC AGENTS; FACIAL DERMATOSES; FEMALE; HUMANS; HYDROCORTISONE; MALE; PEPTIDYLPROLYL ISOMERASE; SEVERITY OF ILLNESS INDEX; SINGLE-BLIND METHOD; TACROLIMUS; TREATMENT OUTCOME;

EID: 33747605048     PISSN: 0003987X     EISSN: 0003987X     Source Type: Journal    
DOI: 10.1001/archderm.142.8.1066     Document Type: Article

References (5)

1. Faergemann J. Pityrosporum infections. J Am Acad Dermatol. 1994;31:S18-S20.
2. Crutchfield CE III. Pimecrolimus: a new treatment for seborrheic dermatitis. Cutis. 2002;70:207-208.
3. Brownell I, Quan LT, Hsu S. Topical pimecrolimus in the treatment of seborrheic dermatitis. Dermatol Online J. 2003;9:13.
4. Rallis E, Nasiopoulou A, Kouskoukis C, Koumantaki E. Pimecrolimus cream 1% can be an effective treatment for seborrheic dermatitis of the face and trunk. Drugs Exp Clin Res. 2004;30:191-195.
5. Rigopoulos D, Ioannides D, Kalogeromitros D, Gregoriou S, Katsambas A. Pimecrolimus cream 1% vs betamethasone 17-valerate 0.1% cream in the treatment of seborrhoeic dermatitis: a randomized open-label clinical trial. Br J Dermatol. 2004;151:1071-1075.